• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高凝状态的实验室指标。

Laboratory markers of hypercoagulability.

作者信息

Rossi M L, Merlini P A, Ardissino D

机构信息

A. De Gasperis Cardiology Department, Hospital Niguarda Ca' Granda, Milan, Italy.

出版信息

Ital Heart J. 2001 Jul;2(7):490-4.

PMID:11501955
Abstract

Investigations carried out over the last 40 years have demonstrated that coronary artery thrombosis is the critical event underlying myocardial infarction and unstable angina. The existence of a prolonged hypercoagulable state preceding the thrombotic event has been postulated for some time and significant associations have been established between the plasma concentrations of a number of hemostatic variables and the frequency of myocardial infarction. High plasma fibrinogen, factor VII/VIIa, tissue-type plasminogen activator and plasminogen activator inhibitor levels have been associated with at least as great a risk of developing myocardial (re)infarction or sudden death as high cholesterol levels, especially in the young. In the last year more sensitive assays have been developed, and they should allow a precise biochemical definition of hypercoagulable states. The significance of these new assays and their role in defining a hypercoagulable state in different conditions are analyzed.

摘要

过去40年所做的研究表明,冠状动脉血栓形成是心肌梗死和不稳定型心绞痛的关键事件。血栓形成事件之前存在长期高凝状态这一假设已提出一段时间,并且已经确定了许多止血变量的血浆浓度与心肌梗死发生率之间的显著关联。高血浆纤维蛋白原、因子VII/VIIa、组织型纤溶酶原激活物和纤溶酶原激活物抑制剂水平与高胆固醇水平至少具有同样大的发生心肌(再)梗死或猝死的风险,尤其是在年轻人中。去年开发出了更灵敏的检测方法,这些方法应能对高凝状态进行精确的生化定义。本文分析了这些新检测方法的意义及其在不同情况下定义高凝状态中的作用。

相似文献

1
Laboratory markers of hypercoagulability.高凝状态的实验室指标。
Ital Heart J. 2001 Jul;2(7):490-4.
2
Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes.急性冠状动脉综合征患者的组织因子途径抑制剂、天然凝血抑制剂及止血激活标志物
Saudi Med J. 2005 Jun;26(6):937-42.
3
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?经历过急性心肌梗死的患者与稳定型劳力性心绞痛患者的凝血和纤溶血浆生物标志物有差异吗?
Am Heart J. 2007 Dec;154(6):1059-64. doi: 10.1016/j.ahj.2007.09.015.
4
Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.首次心肌梗死后,随访时间中位数为8年期间,血浆C反应蛋白和止血因子的变化。
Blood Coagul Fibrinolysis. 2009 Jul;20(5):340-6. doi: 10.1097/MBC.0b013e32832a5fd1.
5
[Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].[非ST段抬高型不稳定型心绞痛和心肌梗死的炎症研究。超敏C反应蛋白的价值]
An Med Interna. 2002 Jun;19(6):283-8.
6
Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction.不稳定型心绞痛与急性心肌梗死之间炎症和血栓形成标志物的差异。
Int J Cardiol. 2007 Feb 7;115(2):203-7. doi: 10.1016/j.ijcard.2006.03.011. Epub 2006 Jun 19.
7
Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.非ST段抬高型急性冠脉综合征患者止血和炎症标志物的短期预后比较价值
Ital Heart J. 2002 Jan;3(1):28-33.
8
Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.阿托伐他汀早期治疗对血脂正常的不稳定型心绞痛患者血栓形成过程的影响。
Int J Cardiol. 2006 Jan 26;106(3):333-7. doi: 10.1016/j.ijcard.2005.02.011.
9
C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.非ST段抬高型急性冠脉综合征中的C反应蛋白、血栓前状态失衡与内皮功能障碍
Rom J Intern Med. 2004;42(1):95-102.
10
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.

引用本文的文献

1
Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome.肥胖对多囊卵巢综合征高凝状态的代谢影响。
Sci Rep. 2021 Mar 5;11(1):5320. doi: 10.1038/s41598-021-84586-y.